Signaling Pathways - Neurocognitive Disorders - Immunosuppressive Therapy - Lung Carcinoma - Bladder Carcinoma
清除全部
-
B2186 GSK2636771Target: PI3KSummary: PIK3抑制剂 -
B2173 CP-673451Target: PDGFRSummary: PDGFRα/β抑制剂 -
A1196 SGX-5231 CitationTarget: METSummary: 高度选择性的、ATP竞争性的Met抑制剂 -
A1821 Ki8751Target: VEGFRSummary: VEGFR-2有效的、选择性抑制剂 -
A3712 PF-04217903 methanesulfonateTarget: c-METSummary: c-Met抑制剂 -
A3573 LY2801653Target: METSummary: MET抑制剂 -
A3191 Ascomycin(FK 520)中文名: 长川霉素Target: phosphatasesSummary: FK-520 类似物，大环内酯类免疫抑制剂 -
A4383 Tolcapone中文名: 托卡朋Target: Catechol O-Methyltransferase (COMT)Summary: COMT抑制剂 -
A4365 Lovastatin中文名: 洛伐他汀Target: HMG-CoA ReductasesSummary: HMG-CoA还原酶抑制剂 -
A1915 Zebularine1 Citation中文名: 泽布拉林Target: DNA Methyltransferases|Cytidine deaminasesSummary: DNA甲基化抑制剂